nifedipine has been researched along with ketamine in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dragunow, M; Faull, RL; Frith, R; Goulding, M; Mee, E; Ralph, R | 1 |
| Erecińska, M; Silver, IA | 1 |
| Herrera, DG; Robertson, HA | 1 |
| Altura, BM; Altura, BT | 1 |
| Hashimoto, Y; Hirota, K; Ishihara, H; Koh, H; Matsuki, A; Takagi, H | 1 |
| Pei, L; Sun, YF; Zhang, GY; Zong, YY | 1 |
| Cui, ZC; Li, Y; Pei, L; Zhang, GY; Zhu, ZM | 1 |
| Cui, ZC; Li, Y; Pei, L; Yan, JZ; Zhang, GY; Zhu, ZM | 1 |
| Shen, W; Zhang, C; Zhang, G | 2 |
| Li, Y; Pei, L; Zhang, GY | 1 |
| Li, H; Tian, H; Zhang, G; Zhang, Q | 1 |
| Li, H; Zhang, G; Zhang, Q | 1 |
| Shen, WH; Zhang, CY; Zhang, GY | 1 |
| Han, D; Li, HC; Xu, YL; Zhang, GY; Zhang, QG | 1 |
| Gui, ZH; Li, Y; Pei, L; Zhang, GY; Zhu, ZM | 1 |
| Banasr, M; Duman, RS; Dwyer, JM; Fuchikami, M; Lepack, AE | 1 |
| Ali, SF; Dumas, M; Gu, Q; Kanungo, J; Robinson, BL; Tryndyak, V | 1 |
2 review(s) available for nifedipine and ketamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
Topics: Anesthesia; Animals; Arterioles; Blood Pressure; Calcium; Calcium Channel Blockers; Cell Membrane Permeability; Cerebrovascular Circulation; Cerebrovascular Disorders; Coronary Disease; Diabetes Mellitus; Dihydropyridines; Female; Humans; Hypertension; Ketamine; Magnesium; Magnesium Deficiency; Microcirculation; Muscle, Smooth, Vascular; Muscles; Nifedipine; Nisoldipine; Nitrendipine; Nutritional Requirements; Pentobarbital; Pre-Eclampsia; Pregnancy; Pyridines; Rats; Vasoconstrictor Agents; Vasodilator Agents; Venules | 1984 |
23 other study(ies) available for nifedipine and ketamine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Induction of c-fos mRNA and protein in neurons and glia after traumatic brain injury: pharmacological characterization.
Topics: Animals; Brain; Brain Injuries; Epilepsy, Temporal Lobe; Humans; Immunohistochemistry; Ketamine; Male; Mice; Mice, Inbred Strains; Neuroglia; Neurons; Nifedipine; Nucleic Acid Hybridization; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; RNA, Messenger; Tissue Distribution; Trifluoperazine | 1990 |
Intracellular and extracellular changes of [Ca2+] in hypoxia and ischemia in rat brain in vivo.
Topics: Animals; Brain Ischemia; Calcium; Calcium Channels; Cerebral Cortex; Dibenzocycloheptenes; Dizocilpine Maleate; Female; Hippocampus; Ketamine; Male; Membrane Potentials; Microelectrodes; Nifedipine; Oxygen Consumption; Rats; Rats, Inbred Strains; Thalamus | 1990 |
N-methyl-D-aspartate receptors mediate activation of the c-fos proto-oncogene in a model of brain injury.
Topics: Animals; Anticonvulsants; Atropine; Brain; Brain Injuries; Dibenzocycloheptenes; Disease Models, Animal; Dizocilpine Maleate; DNA-Binding Proteins; Female; Gene Expression Regulation; Immunohistochemistry; Ketamine; Male; Nifedipine; Phencyclidine; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Proto-Oncogenes; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter | 1990 |
[Clinical study of total intravenous anesthesia with droperidol, fentanyl and ketamine--effects of nicardipine, diltiazem and nifedipine on intraoperative hypertension].
Topics: Anesthesia, Intravenous; Calcium Channel Blockers; Diltiazem; Droperidol; Female; Fentanyl; Humans; Hypertension; Intraoperative Complications; Ketamine; Male; Middle Aged; Nicardipine; Nifedipine | 1993 |
[Ketamine and nifedipine protect cultured cortical neurons against injurious effect of glutamate].
Topics: Animals; Cells, Cultured; Cerebral Cortex; Drug Synergism; Excitatory Amino Acid Antagonists; Ketamine; L-Lactate Dehydrogenase; Neurons; Nifedipine; Protective Agents; Rats | 1996 |
Mechanisms of regulation of tyrosine phosphorylation of NMDA receptor subunit 2B after cerebral ischemia/reperfusion.
Topics: Animals; Calcium Channel Blockers; Genistein; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Ketamine; Nifedipine; Phosphorylation; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Synaptosomes; Tyrosine; Vanadates | 2000 |
Changes and mechanisms of protein-tyrosine kinase and protein-tyrosine phosphatase activities after brain ischemia/reperfusion.
Topics: Animals; Calcium Channel Blockers; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Ketamine; Nifedipine; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Synaptosomes | 2000 |
Nuclear factor kappaB activation is mediated by NMDA and non-NMDA receptor and L-type voltage-gated Ca(2+) channel following severe global ischemia in rat hippocampus.
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels, L-Type; Cytoplasm; Excitatory Amino Acid Antagonists; Hippocampus; I-kappa B Proteins; Ketamine; Male; NF-kappa B; Nifedipine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Amino Acid; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Time Factors | 2002 |
[Effect of ischemia/reperfusion on the phosphorylation of synaptosomal tyrosine of hippocampus of Mongolian gerbils].
Topics: Animals; Brain Ischemia; Calcium Channels, L-Type; Gerbillinae; Hippocampus; Ketamine; Nifedipine; Phosphorylation; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Synaptosomes; Tyrosine | 2000 |
N-methyl-D-aspartate receptor and L-type voltage-gated Ca(2+) channel antagonists suppress the release of cytochrome c and the expression of procaspase-3 in rat hippocampus after global brain ischemia.
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels, L-Type; Caspase 3; Caspase Inhibitors; Cytochrome c Group; Cytosol; Electrophysiology; Enzyme Precursors; Excitatory Amino Acid Antagonists; Hippocampus; Ion Channel Gating; Ketamine; Male; Mitochondria; Nifedipine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Time Factors | 2002 |
Antioxidant NAC and AMPA/KA receptor antagonist DNQX inhibited JNK3 activation following global ischemia in rat hippocampus.
Topics: Acetylcysteine; Animals; Brain Ischemia; Calcium Channel Blockers; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Immunoblotting; Ketamine; Male; Mitogen-Activated Protein Kinase 10; Mitogen-Activated Protein Kinases; Nifedipine; Protein Transport; Protein-Tyrosine Kinases; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Time Factors | 2003 |
Signal transducer and activator of transcription-3 activation is mediated by N-methyl-D-aspartate receptor and L-type voltage-gated Ca2+ channel during cerebral ischemia in rat hippocampus.
Topics: Active Transport, Cell Nucleus; Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels, L-Type; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Hippocampus; Immunoblotting; Ketamine; Male; Nifedipine; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; STAT3 Transcription Factor; Trans-Activators; Tyrosine | 2003 |
Ischemia-induced release of cytochrome c from mitochondria and up-regulation of Bcl-2 expression in rat hippocampus.
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels, L-Type; Cytochromes c; Cytosol; Hippocampus; Ketamine; Male; Mitochondria; Nifedipine; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Up-Regulation | 2004 |
NMDA receptor/L-VGCC-dependent expression and AMPA/KA receptor-dependent activation of c-Jun induced by cerebral ischemia in rat hippocampus.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Carotid Stenosis; Enzyme Activation; Hippocampus; Ischemic Attack, Transient; JNK Mitogen-Activated Protein Kinases; Ketamine; Male; Nifedipine; Phosphorylation; Protein Binding; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Reperfusion; Transcription Factor AP-1 | 2006 |
[Effects of ischemia/reperfusion on the phosphotyrosine proteins contents in hippocampus].
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels; Excitatory Amino Acid Antagonists; Gerbillinae; Hippocampus; Ketamine; Nifedipine; Phosphorylation; Phosphotyrosine; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2001 |
BDNF release is required for the behavioral actions of ketamine.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Depressive Disorder; Ketamine; Male; Neurons; Nifedipine; Prefrontal Cortex; Rats, Sprague-Dawley; Receptors, AMPA; Verapamil | 2014 |
Nifedipine toxicity is exacerbated by acetyl l-carnitine but alleviated by low-dose ketamine in zebrafish in vivo.
Topics: Acetylcarnitine; Animals; Calcium Channel Blockers; Cardiotoxicity; Embryo, Nonmammalian; Humans; Ketamine; Models, Animal; Nifedipine; Zebrafish | 2020 |